Home › Drug Codes › J Codes › J3489 · RECLAST
Updated July 1st, 2026

RECLAST J Code: J3489

Injection, zoledronic acid, 1 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J3489, effective October 1, 2026: $17.673 per HCPCS billing unit, up 425.8% from $3.361. From CMS's final file.

?
Medicare Payment Limit ?
$3.361
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
35
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, zoledronic acid, 1 mg
HCPCS Added Date January 1, 2014
Manufacturer Multiple Manufacturers
Route of Administration Intravenous
Generic Status Multi-Source; Generic
Dosage Type Single-Dose
Dosage Form Injection | Injection, Solution | Injection, Solution, Concentrate | Not Available

About RECLAST

Reclast is a medication aligned to the HCPCS J Code: J3489 for billing, pricing, and reimbursement purposes in the United States. This Osteoporosis medication is administered via the intravenous route and manufactured by multiple companies.

According to CMS Drug Use Information: This medication is used to treat a certain type of bone disease (Paget's disease) that causes abnormal and weak bones. Zoledronic acid is also used to treat bone loss (osteoporosis) in men and in women after menopause who are at high risk of having broken bones (fractures). It may also be used to treat or prevent osteoporosis in people who are taking corticosteroid medications (such as prednisone) for long periods. It works by slowing the breakdown of bone and keeping bones strong. It also helps to reduce the risk of broken bones (fractures). This medication belongs to a class of drugs known as bisphosphonates.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 35 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00078-0435-61 Reclast Sandoz Inc. 5 5 MG / 100 ML
16714-0815-01 Zoledronic Acid Northstar RxLLC 4 4 MG / 5 ML
16729-0242-31 Zoledronic acid Accord Healthcare Inc. 4 4 MG / 5 ML
23155-0170-31 Zoledronic acid Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 4 4 MG / 5 ML
25021-0801-66 Zoledronic Acid Sagent Pharmaceuticals 4 4 MG / 5 ML
•••••-••••-•• Log in to view RECLAST
RECLAST
RECLAST
Login to view 30 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

RECLAST Pricing & Reimbursement

J3489 Private Payer Reimbursement
$5.14 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

RECLAST Claims Performance

Claims from Jan 2026 – Aug 2026
Claim Denial Rate 9.81%
Avg. Days to File 7.5days
Avg. Days to Pay 22.6days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J3489 claims analytics on FocalPoint →
OnPoint Oncology

RECLAST CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
JW / JZ modifiers apply

CMS has identified Reclast (J3489) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

RECLAST Medically Unlikely Edits (MUE)

The most billing units of J3489 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient
5 units / day
= 5 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

RECLAST Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Glucocorticoid-Induced Osteoporosis Glucocorticoid-induced osteoporosis Hypercalcemia of Malignancy Multiple Myeloma and Bone Metastases of Solid Tumors Osteoporosis in Men Osteoporosis in Postmenopausal Women Osteoporosis in men Osteoporosis in postmenopausal women Paget's Disease of Bone Paget's disease of bone
Drug Class
Bisphosphonate [EPC]Diphosphonates [CS]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.
Access Full Report →

Frequently Asked Questions

Is there an available Reclast billing and coding guide?
We have not yet identified a manufacturer source of Reclast billing and coding information.
Are there any available Reclast patient assistance programs?
Our team did not identify a source for Reclast patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Reclast prescribing information?
RECLAST prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date. Visit Here →
Where can I find Reclast side effect information?
Our team has not yet identified a source of side effects information for RECLAST. Please check back in a few weeks.
Does billing RECLAST require JZ/JW wastage modifiers?
CMS has identified RECLAST(J3489) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.

Related Drug Codes

Explore billing, coding, and pricing for drugs related to RECLAST.

J0897PROLIAInjection, denosumab, 1 mgAmgenAdded January 1, 2012J2430PAMIDRONATE DISODIUMInjection, pamidronate disodium, per 30 mgMultiple ManufacturersAdded January 1, 1982Q5136JubbontiInjection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mgSandozAdded October 1, 2024Q5157STOBOCLO AND OSENVELTInjection, denosumab-bmwo (stoboclo/osenvelt), biosimilar, 1 mgCelltrion USAAdded October 1, 2025Q5158CONEXXENCEInjection, denosumab-bnht (bomyntra/conexxence), biosimilar, 1 mgFresenius KabiAdded October 1, 2025Q5161Aukelso and BosayaInjection, denosumab-kyqq (aukelso/bosaya), biosimilar, 1 mgBiocon Biologics IncAdded April 1, 2026Q5162BildyosInjection, denosumab-nxxp (bildyos/bilprevda), biosimilar, 1 mgOrganonAdded April 1, 2026Q5166Osvyrti PFSInjection, denosumab-desu (osvyrti/jubereq), biosimilar, 1 mgAccordAdded July 1, 2026Q5167EnobyInjection, denosumab-qbde (enoby/xtrenbo), biosimilar, 1 mgHikmaAdded July 1, 2026J0630MIACALCINInjection, calcitonin salmon, up to 400 unitsMultiple ManufacturersAdded January 1, 1982